ロード中...

Differences in Response to Fetal Hemoglobin Induction Therapy in β-Thalassemia and Sickle Cell Disease

Inducers of fetal hemoglobin (HbF) have shown considerable promise in the treatment of sickle cell disease (SCD). However, the same agents have shown less clinical activity in β-thalassemia (β-Thal). To understand the basis of these differences in clinical effectiveness, we compared the effects of b...

詳細記述

保存先:
書誌詳細
主要な著者: Fathallah, Hassana, Taher, Ali, Bazarbachi, Ali, Atweh, George F.
フォーマット: Artigo
言語:Inglês
出版事項: 2009
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC2707824/
https://ncbi.nlm.nih.gov/pubmed/19346141
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bcmd.2009.02.006
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!